VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price traded up 76.5% during trading on Friday . The company traded as high as C$0.16 and last traded at C$0.15. 3,992,349 shares traded hands during trading, an increase of 1,549% from the average session volume of 242,055 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Stock Performance
The firm has a market capitalization of C$18.65 million, a price-to-earnings ratio of -3.55 and a beta of 0.39. The firm’s 50-day moving average price is C$0.10 and its two-hundred day moving average price is C$0.13. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- What is the Nikkei 225 index?
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- How to Invest in Small Cap Stocks
- 5 Best Gold ETFs for March to Curb Recession Fears
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
